645 related articles for article (PubMed ID: 17973865)
21. Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets.
Bani D; Bigazzi M; Masini E; Bani G; Sacchi TB
Lab Invest; 1995 Nov; 73(5):709-16. PubMed ID: 7474945
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of nitric oxide synthase activity in human platelets by nitroglycerin and authentic nitric oxide.
Chen LY; Mehta JL
J Investig Med; 1997 Feb; 45(2):69-74. PubMed ID: 9084577
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide modulates air embolism-induced lung injury in rats with normotension and hypertension.
Liu YC; Kao SJ; Chuang IC; Chen HI
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1173-80. PubMed ID: 17880373
[TBL] [Abstract][Full Text] [Related]
24. Defective nitric oxide-cyclic guanosine monophosphate signaling in patients with bipolar disorder: a potential role for platelet dysfunction.
Fontoura PC; Pinto VL; Matsuura C; Resende Ade C; de Bem GF; Ferraz MR; Cheniaux E; Brunini TM; Mendes-Ribeiro AC
Psychosom Med; 2012 Oct; 74(8):873-7. PubMed ID: 23023680
[TBL] [Abstract][Full Text] [Related]
25. Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature.
Emerson M; Momi S; Paul W; Alberti PF; Page C; Gresele P
Thromb Haemost; 1999 Jun; 81(6):961-6. PubMed ID: 10404776
[TBL] [Abstract][Full Text] [Related]
26. The role of inhibition of nitric oxide synthesis in the aggregation of platelets due to the stimulated production of thromboxane A2.
Banerjee D; Mazumder S; Sinha AK
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):585-91. PubMed ID: 25083729
[TBL] [Abstract][Full Text] [Related]
27. Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects.
Schlaich MP; Parnell MM; Ahlers BA; Finch S; Marshall T; Zhang WZ; Kaye DM
Circulation; 2004 Dec; 110(24):3680-6. PubMed ID: 15569830
[TBL] [Abstract][Full Text] [Related]
28. Platelet nitric oxide synthesis in uremia and malnutrition: a role for L-arginine supplementation in vascular protection?
Brunini TM; Mendes-Ribeiro AC; Ellory JC; Mann GE
Cardiovasc Res; 2007 Jan; 73(2):359-67. PubMed ID: 17078937
[TBL] [Abstract][Full Text] [Related]
29. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
[TBL] [Abstract][Full Text] [Related]
30. Increased superoxide production in hypertensive patients with diabetes mellitus: role of nitric oxide synthase.
Dixon LJ; Hughes SM; Rooney K; Madden A; Devine A; Leahey W; Henry W; Johnston GD; McVeigh GE
Am J Hypertens; 2005 Jun; 18(6):839-43. PubMed ID: 15925745
[TBL] [Abstract][Full Text] [Related]
31. Nitridergic platelet pathway activation by hementerin, a metalloprotease from the leech Haementeria depressa.
Chudzinski-Tavassi AM; Bermej E; Rosenstein RE; Faria F; Sarmiento MI; Alberto F; Sampaio MU; Lazzari MA
Biol Chem; 2003 Sep; 384(9):1333-9. PubMed ID: 14515997
[TBL] [Abstract][Full Text] [Related]
32. Aspirin and clopidogrel treatment impair nitric oxide biosynthesis by platelets.
O'Kane PD; Reebye V; Ji Y; Stratton P; Jackson G; Ferro A
J Mol Cell Cardiol; 2008 Aug; 45(2):223-9. PubMed ID: 18606420
[TBL] [Abstract][Full Text] [Related]
33. Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity.
O'Kane P; Xie L; Liu Z; Queen L; Jackson G; Ji Y; Ferro A
Cardiovasc Res; 2009 Jul; 83(1):123-30. PubMed ID: 19377066
[TBL] [Abstract][Full Text] [Related]
34. The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents.
Russo I; Doronzo G; Mattiello L; De Salve A; Trovati M; Anfossi G
Thromb Res; 2004; 114(4):265-73. PubMed ID: 15381390
[TBL] [Abstract][Full Text] [Related]
35. Age decreases nitric oxide synthesis and responsiveness in human platelets and increases formation of monocyte-platelet aggregates.
Goubareva I; Gkaliagkousi E; Shah A; Queen L; Ritter J; Ferro A
Cardiovasc Res; 2007 Sep; 75(4):793-802. PubMed ID: 17572401
[TBL] [Abstract][Full Text] [Related]
36. The insulin-induced increase of guanosine-3',5'-cyclic monophosphate in human platelets is mediated by nitric oxide.
Trovati M; Massucco P; Mattiello L; Piretto V; Cavalot F; Mularoni E; Anfossi G
Diabetes; 1996 Jun; 45(6):768-70. PubMed ID: 8635651
[TBL] [Abstract][Full Text] [Related]
37. Dengue fever activates the L-arginine-nitric oxide pathway: an explanation for reduced aggregation of human platelets.
Mendes-Ribeiro AC; Moss MB; Siqueira MA; Moraes TL; Ellory JC; Mann GE; Brunini TM
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1143-6. PubMed ID: 18505438
[TBL] [Abstract][Full Text] [Related]
38. Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels.
Yemisci M; Ay H; Kocaefe C; Qui J; Topalkara K; Ozgüç M; Kirazli S; Ozcebe O; Moskowitz MA; Dalkara T
Cerebrovasc Dis; 2008; 26(2):190-8. PubMed ID: 18628618
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
[TBL] [Abstract][Full Text] [Related]
40. Studies on the importance of the proposed release of nitric oxide from platelets.
Mollace V; Salvemini D; Vane J
Thromb Res; 1991 Dec; 64(5):533-42. PubMed ID: 1725563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
